Back
60 Degrees Pharmaceuticals, Inc. 10K Form
Sell
42
SXTP
60 Degrees Pharmaceuticals, Inc.
Last Price:
$5.10
Seasonality Move:
-46.57%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SXTP News And Ratings
See the #1 stock for the next 7 days that we like better than SXTP
SXTP Financial Statistics
Sales & Book Value
| Annual Sales: | $681.3K |
|---|---|
| Cash Flow: | $-2.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-1.25 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -7.32300 |
|---|---|
| Net Income (TTM): | $-8M |
| Gross Margin: | $296.6K |
| Return on Equity: | -193.16% |
| Return on Assets: | -132.46% |
60 Degrees Pharmaceuticals, Inc. Earnings Forecast
Key 60 Degrees Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 5 years for SXTP is 43.53%.
-
The Selling, General & Administrative Expenses for SXTP have been equal to 737.56% of Gross Profit Margin.
-
The Research & Development expenses have been 731.91% of Revenue.
-
The Net Earning history of SXTP is -1,167.74% of Total Revenues.
-
Per Share Earnings over the last 5 years have been positive in 1 years.
60 Degrees Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | SXTP |
| Website: | 60degreespharma.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 2.87 |
| Quick Ratio: | 2.18 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SXTP Technical Analysis vs Fundamental Analysis
Sell
42
60 Degrees Pharmaceuticals, Inc. (SXTP)
is a Sell
Is 60 Degrees Pharmaceuticals, Inc. a Buy or a Sell?
-
60 Degrees Pharmaceuticals, Inc. stock is rated a SellThe current 60 Degrees Pharmaceuticals, Inc. [SXTP] share price is $4.84. The Score for SXTP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.